Equity Overview
Price & Market Data
Price: $0.695
Daily Change: +$0.0043 / 0.62%
Daily Range: $0.671 - $0.738
Market Cap: $15,864,887
Daily Volume: 245,192
Performance Metrics
1 Week: -10.64%
1 Month: -11.38%
3 Months: -33.74%
6 Months: -42.12%
1 Year: -61.68%
YTD: -8.75%
Company Details
Employees: 23
Sector: Health technology
Industry: Medical specialties
Country:
Details
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.